Indication:

Olodaterol and tiotropium is a combination medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema. It is important to note that this medication is for use only in people with COPD and should not be used to treat asthma. The combination of olodaterol and tiotropium is designed to help control symptoms of breathing problems, allowing individuals to stay active. It is available as an inhalation aerosol and is classified as a bronchodilator combination.

Dosage:

The detailed dosage information for olodaterol and tiotropium is as follows:

• The typical dosage for adults is two puffs of the inhalation aerosol once daily, with each actuation from the inhaler equivalent to a delivered dose of tiotropium/olodaterol 2.5/2.5 mcg.
• It is important to use this medicine only as directed by a doctor. It should not be used more often or for a longer time than prescribed.
• The medication is not indicated to treat acute deterioration of COPD (i.e., as rescue therapy for the treatment of acute episodes of bronchospasm) or for the treatment of asthma.
• Patients should not stop using this medicine or any asthma medicine without informing their doctor, as doing so may increase the chance of breathing difficulties.

It is crucial to follow the specific dosage instructions provided by the prescribing healthcare provider and to seek medical advice for any questions or concerns regarding the use of olodaterol and tiotropium.

This information is based on the available search results and should not replace the advice of a healthcare professional.